DE60137046D1 - Verwendung von ultraviolett, nahultraviolett und nahinfrarot-resonanzrmanspektroskopie und fluoresenzspektoskopie zur gewebeuntersuchung auf schockzustand, kritische krankheiten oder andere krankheitszustände - Google Patents

Verwendung von ultraviolett, nahultraviolett und nahinfrarot-resonanzrmanspektroskopie und fluoresenzspektoskopie zur gewebeuntersuchung auf schockzustand, kritische krankheiten oder andere krankheitszustände

Info

Publication number
DE60137046D1
DE60137046D1 DE60137046T DE60137046T DE60137046D1 DE 60137046 D1 DE60137046 D1 DE 60137046D1 DE 60137046 T DE60137046 T DE 60137046T DE 60137046 T DE60137046 T DE 60137046T DE 60137046 D1 DE60137046 D1 DE 60137046D1
Authority
DE
Germany
Prior art keywords
spectroscopy
shock
nahultraviolet
frarot
fluoresis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60137046T
Other languages
English (en)
Inventor
Kevin R Ward
R Wayne Barbee
James Terner
Rao R Ivatury
Fred Hawkridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Commonwealth University
Original Assignee
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Commonwealth University filed Critical Virginia Commonwealth University
Application granted granted Critical
Publication of DE60137046D1 publication Critical patent/DE60137046D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412—Detecting or monitoring sepsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60137046T 2000-07-13 2001-07-13 Verwendung von ultraviolett, nahultraviolett und nahinfrarot-resonanzrmanspektroskopie und fluoresenzspektoskopie zur gewebeuntersuchung auf schockzustand, kritische krankheiten oder andere krankheitszustände Expired - Lifetime DE60137046D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21805500P 2000-07-13 2000-07-13
PCT/US2001/022187 WO2002007585A2 (en) 2000-07-13 2001-07-13 Tissue interrogation spectroscopy

Publications (1)

Publication Number Publication Date
DE60137046D1 true DE60137046D1 (de) 2009-01-29

Family

ID=22813555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137046T Expired - Lifetime DE60137046D1 (de) 2000-07-13 2001-07-13 Verwendung von ultraviolett, nahultraviolett und nahinfrarot-resonanzrmanspektroskopie und fluoresenzspektoskopie zur gewebeuntersuchung auf schockzustand, kritische krankheiten oder andere krankheitszustände

Country Status (6)

Country Link
US (1) US7113814B2 (de)
EP (1) EP1304955B1 (de)
AT (1) ATE417543T1 (de)
AU (1) AU2001272003A1 (de)
DE (1) DE60137046D1 (de)
WO (1) WO2002007585A2 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080064108A1 (en) * 1997-12-10 2008-03-13 Tony Baker Urine Preservation System
US7569342B2 (en) * 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
WO2003073082A1 (en) * 2002-02-28 2003-09-04 Erasmus Universiteit Rotterdam Depth selective ph measurement and uv exposure measurement
IL148795A0 (en) * 2002-03-20 2002-09-12 Vital Medical Ltd Apparatus and method for monitoring tissue vitality parameters for the diagnosis of body metabolic emergency state
US7725144B2 (en) * 2002-04-04 2010-05-25 Veralight, Inc. Determination of disease state using raman spectroscopy of tissue
WO2004000112A2 (en) * 2002-06-25 2003-12-31 Glucon Inc. Method and apparatus for determining tissue viability
DE10311452B4 (de) * 2003-03-15 2006-04-13 Roche Diagnostics Gmbh Analysesystem zur reagenzienfreien Bestimmung der Konzentration eines Analyten im lebenden Gewebe
WO2004097365A2 (en) * 2003-04-30 2004-11-11 Mcgill University Method and system for measuring lactate levels in vivo
US7463562B2 (en) * 2003-04-30 2008-12-09 Samsung Electronics Co., Ltd. Method of recording temporary defect list on write-once recording medium, method of reproducing the temporary defect list, recording and/or reproducing apparatus, and the write-once recording medium
JP2006527018A (ja) 2003-06-06 2006-11-30 コーニンクレッカ　フィリップス　エレクトロニクス　エヌ　ヴィ 血液のｐＨ特定のための装置および方法
WO2005052558A1 (en) * 2003-11-28 2005-06-09 Bc Cancer Agency Multimodal detection of tissue abnormalities based on raman and background fluorescence spectroscopy
US20050197544A1 (en) * 2004-02-24 2005-09-08 Bernstein Steven L. System and method for indexing emergency department crowding
US20050215876A1 (en) * 2004-03-25 2005-09-29 Eastman Kodak Company Method and system for automatic image adjustment for in vivo image diagnosis
WO2006014736A2 (en) * 2004-07-21 2006-02-09 Barbour Randall L Method and system for temporal spectral imaging
US8548570B2 (en) 2004-11-29 2013-10-01 Hypermed Imaging, Inc. Hyperspectral imaging of angiogenesis
GB0426993D0 (en) 2004-12-09 2005-01-12 Council Cent Lab Res Councils Apparatus for depth-selective raman spectroscopy
AU2013202796B2 (en) * 2004-12-28 2016-06-09 Hypermed Imaging, Inc. Hyperspectral/multispectral imaging in determination, assessment and monitoring of systemic physiology and shock
JP5149015B2 (ja) * 2004-12-28 2013-02-20 ハイパーメツド・イメージング・インコーポレイテツド 全身生理機能およびショックの決定、評価および監視におけるハイパースペクトル／マルチスペクトルイメージング
WO2006107947A2 (en) 2005-04-04 2006-10-12 Hypermed, Inc. Hyperspectral imaging in diabetes and peripheral vascular disease
WO2006112789A1 (en) * 2005-04-18 2006-10-26 Gasporox Ab Human cavity gas measurement device and method
WO2006116637A2 (en) * 2005-04-27 2006-11-02 Massachusetts Institute Of Technology Raman spectroscopy for non-invasive glucose measurements
WO2007014173A2 (en) * 2005-07-22 2007-02-01 Massachusetts Institute Of Technology Intrinsic raman spectroscopy
CA2658811C (en) * 2005-07-25 2014-03-18 Massachusetts Institute Of Technology Multi modal spectroscopy
FR2890747B1 (fr) * 2005-09-15 2008-05-09 Flowgene Sa Methode et dispositif d'analyse de composes chimiques
GB0606891D0 (en) 2006-04-05 2006-05-17 Council Cent Lab Res Councils Raman Analysis Of Pharmaceutical Tablets
CA2675826A1 (en) * 2006-01-30 2007-08-02 Cardiosense Ltd. Apparatus, system and method for determining cardio-respiratory state
US7838825B2 (en) * 2006-02-13 2010-11-23 Ahura Scientific Inc. Method and apparatus for incorporating electrostatic concentrators and/or ion mobility separators with Raman, IR, UV, XRF, LIF and LIBS spectroscopy and/or other spectroscopic techniques
US20070265513A1 (en) * 2006-05-11 2007-11-15 Schenkman Kenneth A Optical measurement of mitochondrial function in blood perfused tissue
US20080200780A1 (en) * 2006-05-11 2008-08-21 Schenkman Kenneth A Optical measurement of cellular energetics
US8126527B2 (en) * 2006-08-03 2012-02-28 University Of Washington Through Its Center For Commercialization Method and system for determining the contribution of hemoglobin and myoglobin to in vivo optical spectra
US8560059B2 (en) * 2007-03-09 2013-10-15 Covidien Lp System and methods for optical sensing and drug delivery using microneedles
US7713196B2 (en) 2007-03-09 2010-05-11 Nellcor Puritan Bennett Llc Method for evaluating skin hydration and fluid compartmentalization
US8081305B2 (en) * 2007-05-21 2011-12-20 Ahura Scientific Inc. Preparing samples for optical measurement
US7675611B2 (en) 2007-05-21 2010-03-09 Ahura Scientific Inc. Handheld infrared and Raman measurement devices and methods
US8165676B2 (en) 2007-12-21 2012-04-24 Medtronic, Inc. Optical sensor and method for detecting a patient condition
US8260415B2 (en) 2007-12-21 2012-09-04 Medtronic, Inc. Optical sensor and method for detecting a patient condition
US8338127B2 (en) 2008-01-31 2012-12-25 Anazyme Testing a mammal for presence, progression or stage of a shock condition
US20090281536A1 (en) * 2008-05-09 2009-11-12 Hugh Beckman Medical Device For Diagnosing and Treating Anomalous Tissue and Method for Doing the Same
CA3162577C (en) 2008-05-20 2023-09-26 University Health Network Device and method for fluorescence-based imaging and monitoring
WO2010127249A1 (en) 2009-05-01 2010-11-04 Wayne State University Light therapy treatment
US10071261B2 (en) 2009-05-01 2018-09-11 Wayne State University Light therapy treatment
EP2451344B1 (de) 2009-07-10 2019-02-20 Cas Medical Systems, Inc. Verfahren zur spektrofotometrischen überwachung der sauerstoffanreicherung im blut des unteren magen-darm-trakts
GB201000179D0 (en) 2010-01-07 2010-02-24 Rsp Systems As Apparatus for non-invasive in vivo measurement by raman spectroscopy
US8649008B2 (en) * 2010-02-04 2014-02-11 University Of Southern California Combined spectral and polarimetry imaging and diagnostics
EP2635185A4 (de) 2010-11-03 2014-12-24 Univ Washington Through Its Ct For Com Ization Bestimmung der in-vivo-sauerstoffanreicherung eines gewebes
US8854618B2 (en) * 2011-06-28 2014-10-07 The United States Of America As Represented By The Secretary Of The Army Hand-held raman laser device for distant life-death determination by molecular peri-mortem plume fuzzy membership function
RU2486515C1 (ru) * 2011-11-03 2013-06-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Казанский национальный исследовательский технический университет им. А.Н Туполева-КАИ" (КНИТУ-КАИ) Способ определения функциональной состоятельности кожно-мышечного трансплантата при пластике дефектов кожи и мягких тканей
US9291550B1 (en) 2012-04-12 2016-03-22 Nicholas Wing Device and method for instantaneous drug testing in the field
WO2014168734A1 (en) 2013-03-15 2014-10-16 Cedars-Sinai Medical Center Time-resolved laser-induced fluorescence spectroscopy systems and uses thereof
CN109171761A (zh) 2013-05-02 2019-01-11 Atonarp株式会社 对生物体进行监视的监视器和系统
US10925515B2 (en) 2014-05-22 2021-02-23 Picomole Inc. Alveolar breath collection apparatus
CN115989999A (zh) 2014-07-24 2023-04-21 大学健康网络 用于诊断目的的数据的收集和分析
CN104173059A (zh) * 2014-09-04 2014-12-03 电子科技大学 一种光学非侵入式休克监护仪及其检测方法
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
US9726679B2 (en) 2015-07-28 2017-08-08 King Saud University Spectral method for quantifying hemoglobin fragility caused by smoking
KR102396249B1 (ko) 2015-10-14 2022-05-09 삼성전자주식회사 라만 스펙트럼을 이용한 사용자 인증 장치 및 방법
US9842868B2 (en) * 2015-10-26 2017-12-12 Sensors Unlimited, Inc. Quantum efficiency (QE) restricted infrared focal plane arrays
WO2017075176A1 (en) * 2015-10-30 2017-05-04 Cedars-Sinai Medical Center Methods and systems for performing tissue classification using multi-channel tr-lifs and multivariate analysis
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
CN115561211A (zh) 2016-04-01 2023-01-03 黑光外科公司 用于时间分辨荧光光谱法的系统、装置和方法
CA2998026A1 (en) 2017-03-13 2018-09-13 Picomole Inc. Apparatus and method of optimizing laser system
WO2019060427A1 (en) * 2017-09-19 2019-03-28 Pendar Technologies, Llc IN VIVO MONITORING OF CELLULAR ENERGY BY RAMAN SPECTROSCOPY
US10952616B2 (en) 2018-03-30 2021-03-23 Canon U.S.A., Inc. Fluorescence imaging apparatus
EP3820360A1 (de) * 2018-07-13 2021-05-19 Koninklijke Philips N.V. Fotoplethysmografie-pulsoximeter zur herz-lungen-wiederbelebung
US10743749B2 (en) 2018-09-14 2020-08-18 Canon U.S.A., Inc. System and method for detecting optical probe connection
US11035789B2 (en) 2019-04-03 2021-06-15 Picomole Inc. Cavity ring-down spectroscopy system and method of modulating a light beam therein
KR20200129409A (ko) * 2019-05-08 2020-11-18 삼성전자주식회사 광 센서, 생체 정보 추정 장치 및 방법
US11957450B2 (en) 2020-02-28 2024-04-16 Picomole Inc. Apparatus and method for collecting a breath sample using an air circulation system
US11782049B2 (en) 2020-02-28 2023-10-10 Picomole Inc. Apparatus and method for collecting a breath sample using a container with controllable volume

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832483A (en) * 1987-09-03 1989-05-23 New England Medical Center Hospitals, Inc. Method of using resonance raman spectroscopy for detection of malignancy disease
US5261410A (en) * 1991-02-07 1993-11-16 Alfano Robert R Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy
US5203328A (en) * 1991-07-17 1993-04-20 Georgia Tech Research Corporation Apparatus and methods for quantitatively measuring molecular changes in the ocular lens
US5919140A (en) * 1995-02-21 1999-07-06 Massachusetts Institute Of Technology Optical imaging using time gated scattered light
US5991653A (en) * 1995-03-14 1999-11-23 Board Of Regents, The University Of Texas System Near-infrared raman spectroscopy for in vitro and in vivo detection of cervical precancers
US5769081A (en) 1996-03-18 1998-06-23 The Research Foundation Of City College Of New York Method for detecting cancerous tissue using optical spectroscopy and fourier analysis
US6008889A (en) * 1997-04-16 1999-12-28 Zeng; Haishan Spectrometer system for diagnosis of skin disease
US6411838B1 (en) * 1998-12-23 2002-06-25 Medispectra, Inc. Systems and methods for optical examination of samples

Also Published As

Publication number Publication date
US7113814B2 (en) 2006-09-26
EP1304955A2 (de) 2003-05-02
WO2002007585A2 (en) 2002-01-31
AU2001272003A1 (en) 2002-02-05
EP1304955A4 (de) 2005-09-28
ATE417543T1 (de) 2009-01-15
US20040039269A1 (en) 2004-02-26
EP1304955B1 (de) 2008-12-17
WO2002007585A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
DE60137046D1 (de) Verwendung von ultraviolett, nahultraviolett und nahinfrarot-resonanzrmanspektroskopie und fluoresenzspektoskopie zur gewebeuntersuchung auf schockzustand, kritische krankheiten oder andere krankheitszustände
Holton et al. Relationship between physiological factors and clinical pain in dogs scored using a numerical rating scale
Marks Jr et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens
Lean et al. Predicting body composition by densitometry from simple anthropometric measurements
DE69230000T2 (de) Verfahren und testsatz zur messung von endogenen zytokinen
Drake et al. Guidelines of care for superficial mycotic infectionsof the skin: Tinea capitis and tinea barbae
TW200501978A (en) Use of FGF-18 in the diagnosis and treatment of memory disorders
Ross et al. The Mental Adjustment to HIV scale: measurement and dimensions of response to AIDS/HIV disease
ATE352039T1 (de) Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung
Leung et al. Rapid tissue viability evaluation using methemoglobin as a biomarker in burns
An et al. FUNCTIONAL STRENGTH MEASUREMENT OF NORMAL FINGERS.
van der Wegen-Keliser et al. Allergy to cane reed in a saxophonist.
Heppenstall Compartment Syndrome: Pathophysiology, diagnosis, and treatment
NOSSIER et al. Validity and Reliability of Arabic Version of the patient and observer scar assessment scale with burned patients
Ralston Neurocysticercosis: an exotic disease presenting in Australian immigrants
Govindaraju Study on Pramana Shareera in relation to Prakriti
ATE387934T1 (de) Aktive implantierbare medizinische vorrichtung, insbesondere herzschrittmacher, resynchronisierer,defibrillator und/oder kardiovertierer, mit hilfsmitteln zur diagnose des zustands eines patienten
Soyinka Recurrent disseminated infundibulofolliculitis.
Zhong ASSESSMENT OF THE VALIDITY AND RELIABILITY OF THE QUESTIONNAIRE OF THE MOTIVATIONAL CLIMATE OF PHYSICAL ACTIVITY IN THE ASPECT OF THE THEORY OF SELF-DETERMINATION
Essien et al. Measuring AIDS fears in health workers: structure of the FAIDSS across countries
Johns Systematic review: Use of the Dermatology Life Quality Index (DLQI) in National and Regional Registries and Guidelines
John et al. Prevalence of Depression in Vitiligo Patients-A Systematic Review and Meta-Analysis
Kim et al. Change in medical care utilization over time in early years of insurance coverage
Hu et al. How Many Measurement Times for Probe Reaction Time could be Yielded Optimum and Reliability?
Heung Study of Relationship between China BeunJungLonChi and DongEuiBoGam BeunJungLonCh

Legal Events

Date Code Title Description
8364 No opposition during term of opposition